NCT00887965View on ClinicalTrials.gov

A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

August 31, 2010

Conditions
Low Bone MassLow Bone Mineral DensityOsteoporosisPostmenopausal Osteoporosis
Interventions
DRUG

Previous denosumab

Participants who had previously received denosumab received a transiliac crest bone biopsy performed following standard labeling procedures with tetracycline or tetracycline derivative.

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00887965 - A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab | Biotech Hunter | Biotech Hunter